Accellent Inc. 10% Senior Subordinated Notes Due 2017 Exchange and Registration Rights AgreementRights Agreement • November 2nd, 2010 • Accellent Inc • Surgical & medical instruments & apparatus • New York
Accellent Inc., a Maryland corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) an aggregate of $315,000,000 principal amount of its 10% Senior Subordinated Notes due 2017, which are guaranteed by the Guarantors identified in the Indenture (as defined herein). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company and the Guarantors agree with the Purchasers for the benefit of holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
SUPPLEMENTAL INDENTURESupplemental Indenture • November 2nd, 2010 • Accellent Inc • Surgical & medical instruments & apparatus • New York
SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of October 28, 2010, by and among Accellent Inc., a Maryland corporation (the “Company”), the guarantors named herein (the “Guarantors”) and The Bank of New York Mellon (formerly known as The Bank of New York), as trustee (the “Trustee”) to the Indenture, dated as of November 22, 2005 (the “Indenture”).
